Medical Xpress news

Medical Xpress / Pills that communicate from the stomach could improve medication adherence

In an advance that could help ensure people are taking their medication on schedule, MIT engineers have designed a pill that can report when it has been swallowed.

Jan 8, 2026 in Medications
Medical Xpress / COVID-19 still claims more than 100,000 US lives each year

Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus 33.0 million illnesses ...

Medical Xpress / Bright light suppresses eating and weight gain in mice

Past research has found that exposure to bright lights and high levels of noise can alter both physiological processes and human behavior. For instance, an elevated or limited exposure to bright lights and noise has been ...

Jan 7, 2026 in Neuroscience
Medical Xpress / Post-stroke injection protects the brain in preclinical study

When a person suffers a stroke, physicians must restore blood flow to the brain as quickly as possible to save their life. But, ironically, that life-saving rush of blood can also trigger a second wave of damage—killing ...

Jan 7, 2026 in Neuroscience
Medical Xpress / Restoring mitochondria shows promise for treating chronic nerve pain

For millions living with nerve pain, even a light touch can feel unbearable. Scientists have long suspected that damaged nerve cells falter because their energy factories known as mitochondria don't function properly.

Medical Xpress / Whooping cough vaccination for pregnant women strengthens babies' immune systems, international study shows

International research led by Radboud University Medical Center shows that vaccinating women during pregnancy leads to the transfer of antibodies to their newborns. Antibodies from the mother are transferred to the baby through ...

Jan 7, 2026 in Obstetrics & gynaecology
Medical Xpress / Single-dose oral cholera vaccine completes phase 1 trial with promising results

A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in a phase 1 clinical trial, with results published in The Lancet Infectious Diseases.

Medical Xpress / How neuron groups team up to embed memories in context

Humans have the remarkable ability to remember the same person or object in completely different situations. We can easily distinguish between dinner with a friend and a business meeting with the same friend. "We already ...

Jan 7, 2026 in Neuroscience
Medical Xpress / Researchers uncover molecular roots of tissue scarring in inflammatory bowel disease

When inflammation in the body goes unchecked, it can cause fibrosis, or tissue scarring that may lead to organ dysfunction or even failure. This can happen in conditions such as inflammatory bowel diseases (ulcerative colitis ...

Jan 7, 2026 in Inflammatory disorders
Medical Xpress / Light-triggered microneedle patch could make IVF hormone delivery painless and automated

A McGill University research team has developed a painless, automated way to deliver in vitro fertilization (IVF) hormones using a light-activated microneedle patch, an innovation that could ease one of the most stressful ...

Jan 7, 2026 in Obstetrics & gynaecology
Medical Xpress / Your genes determine how fast your DNA mutates with age, study shows

An analysis of genetic data from over 900,000 people shows that certain stretches of DNA, made up of short sequences repeated over and over, become longer and more unstable as we age. The study found that common genetic variants ...

Jan 7, 2026 in Genetics
Medical Xpress / New BMI uses AI to reveal hidden metabolic disorders

Researchers at Leipzig University and the University of Gothenburg have developed a novel approach to assessing an individual's risk of metabolic diseases such as diabetes or fatty liver disease more precisely. Instead of ...